重症监护病房鲍曼不动杆菌耐药性分析及防控对策  

Distribution of drug resistance Acinetobacter Baumannii in surgical ICU and its prevention

作　　者：王蓓[1] 杨环[1] 陆晨[2] 易洪仪[2] 

机构地区：[1]新疆维吾尔自治区人民医院感染管理科,乌鲁木齐830001 [2]新疆维吾尔自治区人民医院医务部,乌鲁木齐830001

出　　处：《中华全科医师杂志》2011年第7期495-496,共2页Chinese Journal of General Practitioners

摘　　要：为了解重症监护病房鲍曼不动杆菌的分布特点及耐药性现状，有效预防控制耐药菌产生及传播。本研究对2008年1月至2009年12月外科重症监护病房鲍曼不动杆菌感染患者的298份标本病原学资料进行回顾性调查分析。结果显示外科重症监护病房分离114株鲍曼不动杆菌以下呼吸道感染为主（92株，占80．7％），2009年多重耐药鲍曼不动杆菌检出率（75．7％）与2008年（50．0％）相比明显升高。说明应加强院内耐药菌监控管理工作。Drug resistance of Acinetobacter baumannii （Ab） in surgical ICU from January 2008 to December 2009 was investigated retrospectively. Total 114 clinical strains of Ab were isolated from surgical ICU and 92 strains were from respiratory tract （80. 7% ）. The prevalence rate of multiresistant Ab in 2009 was higher than that in 2008 （75.7% vs 50. 0%, X^2 = 7. 703, P = 0. 006）. The results indicate that to monitor and control drug resistant of Ab constantly is important for the prevention of nosocomial infection.

关 键 词：鲍曼不动杆菌 抗药性 

分 类 号：R446.5[医药卫生—诊断学]